ALISO VIEJO, Calif., June 21, 2007 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced today that its President and CEO, Lloyd Malchow, will be featured in an exclusive live interview to be broadcast on Market News First (www.mn1.com) on Friday, June 22, 2007, at 11:00 a.m. Eastern Time.
Mr. Malchow will update the investment community, providing an overview of the company's business activities and strategic focus. Highlights will include comments on the company's recent receipt of FDA 510(k) clearance for its new Radiation Balloon product and a review of its first quarter results. Additional topics will include the company's current capitalization, its strategic plans for continuing growth, and upcoming key milestones investors should watch for that will drive future performance and shareholder value.
To hear the interview live, simply go to the MN1 website www.mn1.com. The interview will also be archived for replay later in the podcasts section at the bottom of the MN1 site. Market News First is an online, market news provider that brings investors current news on the market.
About SenoRx
SenoRx (Nasdaq:SENO), which completed its initial public offering of common stock in March 2007, develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis of breast cancer. SenoRx's field sales organization serves over 1,000 breast diagnostic and treatment centers in the United States and Canada. With 17 products that have already received FDA 510(k) clearance across the continuum of breast care, SenoRx is developing additional minimally invasive products for diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.
The SenoRx, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3605